drugset / Trial / NCT01922427

Study of RNS60 on Pain and Function After Knee Anterior Cruciate Ligament Surgery

NCT01922427

Phase 2 Withdrawn Revalesio Corporation
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to see if use of RNS60 during ACL reconstruction surgery decreases pain and improves functional capacity post-operation.

Timeline

Start
Primary completion
2014-10
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject RNS60 Other / unclassified

Indications

No indication recorded.